Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy
Recruiting
N/A
Interventional Study
Barrett Esophagus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 137 (estimated)
- Sponsor
- Erasmus Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the Endosign capsule sponge test as a novel surveillance method in patients with an ultralong-segment Barrett's esophagus.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Any participant 18 years and above, with ultralong-segment Barrett's esophagus and clinically fit for an endoscopy
* Ability to provide informed consent
Exclusion Criteria:
* Individuals with a diagnosis of an oro-pharynx, esophageal or gastro-esophageal tumor (T2 staging an…
Contacts